Publicacións (57) Publicacións nas que participase algún/ha investigador/a

2018

  1. A D-alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus

    Virulence, Vol. 9, Núm. 1, pp. 604-620

  2. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

    Advances in Therapy, Vol. 35, Núm. 3, pp. 289-310

  3. A fatal case of Babesia divergens infection in Northwestern Spain

    Ticks and Tick-borne Diseases, Vol. 9, Núm. 3, pp. 730-734

  4. A multicentre study investigating parameters which influence direct bacterial identification from urine

    PLoS ONE, Vol. 13, Núm. 12

  5. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 511-515

  6. Answer to January 2018 Photo Quiz

    Journal of clinical microbiology, Vol. 56, Núm. 1

  7. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

  8. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

    Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076

  9. Borrelia burgdorferi serology and diagnosis of Lyme disease in the healthcare area of Santiago de Compostela (Galicia, Spain): 2006-2016

    Medicina Clinica, Vol. 151, Núm. 4, pp. 162-163

  10. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 5, pp. 284-289

  11. Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006-2017)

    International Journal of Antimicrobial Agents, Vol. 52, Núm. 1, pp. 104-108

  12. Community acquired pneumonia by Legionella pneumophila: Study of 136 cases

    Medicina Clinica, Vol. 151, Núm. 7, pp. 265-269

  13. Comparison of Predictors and Mortality between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae

    Infection Control and Hospital Epidemiology, Vol. 39, Núm. 6, pp. 660-667

  14. Continued propagation of the CRF19_cpx variant among HIV-positive MSM patients in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 4, pp. 1031-1038

  15. Current aspects in sepsis approach. Turning things around

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 4, pp. 298-315

  16. Decline and changing profile of hepatitis delta among injection drug users in Spain

    Antiviral Therapy, Vol. 23, Núm. 1, pp. 87-90

  17. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction

    Scientific Reports, Vol. 8, Núm. 1

  18. Direct identification of clinical pathogens from liquid culture media by MALDI-TOF MS analysis

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 624-629

  19. Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain

    PLoS ONE, Vol. 13, Núm. 8

  20. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522